CA Patent

CA2762013A1 — Granulation of pirfenidone and pharmaceutically acceptable excipients

Assigned to Intermune Inc · Expires 2007-04-05 · 19y expired

What this patent protects

A granulation of pirfenidone is provided that includes pharmaceutically acceptable excipients. Further provided is use of the granulation of pirfenidone for treating fibrotic conditions and other cytokine-mediated disorders.

USPTO Abstract

A granulation of pirfenidone is provided that includes pharmaceutically acceptable excipients. Further provided is use of the granulation of pirfenidone for treating fibrotic conditions and other cytokine-mediated disorders.

Drugs covered by this patent

Patent Metadata

Patent number: CA2762013A1
Jurisdiction: CA
Classification: —
Expires: 2007-04-05
Drug substance claim: No
Drug product claim: No
Assignee: Intermune Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.